ROCKWELL MEDICAL, INC. Debt Securities, Available-for-sale, Current
ROCKWELL MEDICAL, INC. (RMTI) had Debt Securities, Available-for-sale, Current of $14.29 million as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent · last filed 2026-03-26
- 2025-12-31: Debt Securities, Available-for-sale, Current $14.29M.
- 2024-12-31: Debt Securities, Available-for-sale, Current $5.94M.
- 2024-09-30: Debt Securities, Available-for-sale, Current $5.93M.
- 2024-06-30: Debt Securities, Available-for-sale, Current $0.00.
| Period end | Debt Securities, Available-for-sale, Current | Debt Securities, Available-for-sale, Current as first filed |
|---|---|---|
| 2025-12-31 | $14.29M 10-K · filed 2026-03-26 | |
| 2024-12-31 | $5.94M 10-K · filed 2026-03-26 | |
| 2024-09-30 | $5.93M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $1.98M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $1.95M 10-K · filed 2025-03-20 | |
| 2023-09-30 | $3.97M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $5.91M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $5.94M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $11.39M 10-K · filed 2024-03-21 | |
| 2022-09-30 | $14.58M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $9.16M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $9.81M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $8.57M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $10.46M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $10.00M 10-K · filed 2022-04-08 | |
| 2020-09-30 | $10.70M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $13.26M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $11.46M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $14.25M 10-K · filed 2021-03-31 | $14.25M 10-K · filed 2020-03-17 |
| 2018-12-31 | $10.82M 10-K · filed 2020-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |